Under the agreement, AMT will have exclusive marketing and distribution rights for the complete Vision-Sciences’s line of flexible cystoscopes, including the new CST-5000 flexible video cystoscopy system.
Additionally, as part of the agreement, AMT will also have the rights to distribute the TNE-5000 transnasal esophagoscopy system to the gastroenterology market.
Ron Hadani, president and CEO of Vision-Sciences, said: “We are very excited to expand our reach and opportunities in the Canadian market. We truly believe that EndoSheath endoscopy can offer Canada’s physicians an innovative, safe, and efficient option in providing the best endoscopic care for their patients.”